Stock Analysts’ downgrades for Tuesday, October 17th:

8point3 Energy Partners (NASDAQ:CAFD) was downgraded by analysts at Goldman Sachs Group, Inc. (The) from a buy rating to a neutral rating.

Deutsche Boerse Ag (NASDAQ:DBOEY) was downgraded by analysts at J P Morgan Chase & Co from an overweight rating to a neutral rating.

Darden Restaurants (NYSE:DRI) was downgraded by analysts at Argus from a buy rating to a hold rating. The firm currently has $88.00 target price on the stock.

Embraer-Empresa Brasileira de Aeronautica (NYSE:ERJ) was downgraded by analysts at Deutsche Bank AG from a buy rating to a hold rating.

Eaton Corporation, PLC (NYSE:ETN) was downgraded by analysts at Bank of America Corporation to an underperform rating.

Sunoco Logistics Partners (NYSE:ETP) was downgraded by analysts at Goldman Sachs Group, Inc. (The) from a buy rating to a neutral rating.

Freeport-McMoran (NYSE:FCX) was downgraded by analysts at Deutsche Bank AG from a hold rating to a sell rating. They currently have $14.00 target price on the stock.

Ingersoll-Rand PLC (Ireland) (NYSE:IR) was downgraded by analysts at Bank of America Corporation from a buy rating to a neutral rating.

Kaiser Aluminum Corporation (NASDAQ:KALU) was downgraded by analysts at Deutsche Bank AG from a buy rating to a hold rating. The firm currently has $100.00 price target on the stock.

Kinder Morgan (NYSE:KMI) was downgraded by analysts at Goldman Sachs Group, Inc. (The) from a buy rating to a neutral rating.

Rio Tinto PLC (NYSE:RIO) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating.

Syndax Pharmaceuticals (NASDAQ:SNDX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Syndax Pharmaceuticals, Inc. is a biopharmaceutical company which focused on the development and commercialization of entinostat, an epigenetic therapy for treatment-resistant cancers. The Company’s product pipeline includes ENCORE 601, ENCORE 602, J1353, NCI-7870, NCI-9844, E2112, NCI-8871 and NCI-9253 which are in clinical trial stage. Syndax Pharmaceuticals, Inc. is based in WALTHAM, United States. “

Extended Stay America (NYSE:STAY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Extended Stay America, Inc. owns and operates hotels under the core brand, Extended Stay America(R). It is the owner/operator of company-branded hotels in North America. The Company offers guest rooms, dining services, on-site laundry, local phone calls, personalized voicemail, pools, fitness centers, and pet friendly accommodations. Extended Stay America, Inc. is headquartered in Charlotte, North Carolina. “

Targa Resources (NYSE:TRGP) was downgraded by analysts at Goldman Sachs Group, Inc. (The) from a buy rating to a neutral rating.

United Natural Foods (NASDAQ:UNFI) was downgraded by analysts at Royal Bank Of Canada from a sector perform rating to an underperform rating. The firm currently has $34.00 price target on the stock, down from their previous price target of $36.00.

West Pharmaceutical Services (NYSE:WST) was downgraded by analysts at Bank of America Corporation from a buy rating to a neutral rating.

Receive News & Stock Ratings for 8point3 Energy Partners LP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 8point3 Energy Partners LP and related stocks with our FREE daily email newsletter.